Notices
Immunization Techniques Training
Immunization Techniques Training
Wednesday, October 12, 2022, from 8:30 am – 12:00 pm, 1:00 pm – 4:30 pm
Moderna Bivalent Booster Ordering Resumed
Moderna Bivalent Booster Ordering Resumed
Moderna Bivalent Booster ordering has been turned back on in Philavax and Monday.com. Please note: allocations are still limited at this time so providers may not receive what is requested based on dose availability.
Please make sure you are selecting the correct NDC when ordering bivalent boosters (see table below). Selecting the monovalent product code and then selecting booster in the Dose Number column will not allow you to order bivalent doses. You will need to select the correct NDC. All previously submitted orders of bivalent vaccines during the ordering pause will need to be resubmitted for processing.
Become a Monkeypox Vaccine Provider
Become a Monkeypox Vaccine Provider
- Gay, bisexual, transgender, non-binary, and other men who have sex with men, transgender, or non-binary persons
AND meet one of the following criteria:
- Have had multiple or anonymous sex partners in the last 14 days
- Have had any newly diagnosed STI in the past 12 months, including gonorrhea, chlamydia, early syphilis, or HIV
- Have recently attended or plan to attend any venue where anonymous sex or sex with multiple partners will occur (e.g. saunas, bathhouses, sex clubs, sex parties) in the next 30 days
- Have met recent partners or plan to meet new partners in the next 30 days through social media platforms (such as Grindr, Tinder or Scruff), or at clubs, raves, sex parties, saunas
- Sex workers (of any sex or gender), and/or
- Anyone with known close contact (skin-to-skin) with someone with monkeypox in the past 14 days
Moderna Bivalent Ordering Pause
Moderna Bivalent Ordering Pause
Additional VFC & VFAAR Flu Vaccine Presentations Available to Order
Additional VFC & VFAAR Flu Vaccine Presentations Available to Order
- VFC
- Flucelvax prefilled syringes
- Flumist intranasal
- VFAAR
- Flucelvax prefilled syringes
COVID-19 Walk-in Survey
COVID-19 Walk-in Survey
COVID Vaccine Expiration Dates
COVID Vaccine Expiration Dates
- All lots of Orange Cap (5-11) Pfizer shipping out until 8/30/22 will have a 9/30/22 expiration date and must be disposed of by this date. Orange Cap vaccine shipping out after 8/30/22 will have an end of November expiration date and must be disposed of by that date.
- Pfizer has a new lot/expiration date lookup tool – lotexpiry.cvdvaccine.com
- Pfizer Maroon Cap CDC BUDs
- Pfizer Orange Cap CDC BUDs
- Pfizer Gray Cap CDC BUDs
- Moderna lot/expiration date lookup tool
- Moderna Under Five Magenta BUDs
- Moderna 5-11 Purple/Teal AND Red cap Adult Moderna BUDs
- Novavax lot/expiration date lookup tool
- Does not have BUD labels presently as vaccine arrives refrigerated – use manufacture expiration date and use expiration tool to check date prior to each use
- Janssen lot/expiration date lookup tool
- Many lots approaching expiration
- Does not have BUD labels presently as vaccine arrives refrigerated – use manufacture expiration date and use expiration tool to check date prior to each use
Immunization Records Review for Childcare Facilities
Immunization Records Review for Childcare Facilities
Hello Childcare Provider:
On an annual basis, the Pennsylvania Department of Health in collaboration with the Philadelphia Department of Public Health conducts an immunization records review of a random sample of childcare facilities from the Department of Human Services list of childcare group settings throughout the Commonwealth. This year, your facility has been chosen.
The goal of this review is to ensure that all children receive their required immunizations and are protected against vaccine preventable diseases.
During the review, we will examine the immunization records for all children enrolled at your facility and validate their completeness. Per the regulations for childcare facilities, all ACIP recommended vaccines are required for children unless an exemption is on file. This includes an annual flu vaccine.
On the day of the review, we will need access to the Child Health Assessment Form (CD 51) for all children enrolled in your facility who are 2 months through 59 months of age, with a date of birth from 9/2/2017 – 7/1/2022.
The deadline to submit requested information is September 30, 2022.
Please review the attachments below:
Philadelphia Department of Public Health’s correspondence letter
2022 Recommended Immunization for Children (Birth-6 years old)
Thank you for your commitment to keeping children safe and healthy! If you have any questions, please email tanya.jones@phila.gov.
Monkeypox Vaccine Update: Expanded Eligibility & Second Doses
Monkeypox Vaccine Update: Expanded Eligibility & Second Doses
There is now vaccine supply to begin administering a complete two-dose Jynneos vaccine series to each individual who is eligible for vaccine.
Updates
Eligibility for a first dose now includes:
• People of all ages. Subcutaneous administration continues to be required for those <18.
• People with a history of STI in the past 12 months, as well as individuals who plan to have multiple or anonymous sex partners, or those plan to meet new sexual partners via social media.
Eligibility for a second dose now includes:
• People who have received a first Jynneos vaccine dose through either intradermal or subcutaneous administration. This dose should be given intradermally to those 18 and older unless there is a contraindication.
Eligibility has also expanded to include those with a history of STI in the past 12 months (from 6 months previously) and to start offering preexposure prophylaxis to people at high risk for becoming infected. The interval between doses for both subcutaneous and intradermal injections is at minimum 28 days. Individuals who test positive for monkeypox after their first dose should not receive a second dose of vaccine. Individuals whose second doses have been delayed do not need to restart the two-dose vaccine series.
There is no age requirement for Jynneos vaccine eligibility, although those less than 18 years of age must receive the vaccine subcutaneously. Individuals 18 and older will be given intradermal vaccination, regardless of which method was used for the first vaccine, unless there is a contraindication.
Complete eligibility criteria include:
People who meet the following condition:
• Gay, bisexual, transgender, non-binary, and other men who have sex with men, transgender, or non-binary persons
AND meet ONE of the following criteria:
• Have had multiple or anonymous sex partners in the last 14 days
• Have had any newly diagnosed STI in the past 12 months, including gonorrhea, chlamydia, early syphilis, or HIV
• Have recently attended or plan to attend any venue where anonymous sex or sex with multiple partners will occur (e.g. saunas, bathhouses, sex clubs, sex parties) in the next 30 days
• Have met recent partners or plan to meet new partners in the next 30 days through social media platforms (such as Grindr, Tinder or Scruff), or at clubs, raves, sex parties, saunas
Additionally, the following people are eligible:
• Sex workers (of any sex or gender), and/or
• Anyone with known close contact (skin-to-skin) with someone with monkeypox in the past 14 days
When using an intradermal strategy, there may be unused doses in a single vial. All efforts should be made to give doses to the above eligible individuals. If there are doses that would go wasted, they may be given to other individuals not included in the above criteria. Healthcare workers directly involved in testing and examining those with possible monkeypox illness and staff involved in environmental cleaning and disinfection protocols should be prioritized.
Thank you for keeping Philadelphia safe and healthy! If you have any questions about these updates, please contact vaccines@phila.gov.